Baker McKenzie Supports DocMorris Finance B.V. in CHF 45 Million Convertible Bond Placement and 2026 Buyback

Baker McKenzie acted as legal counsel to DocMorris Finance B.V., a wholly owned subsidiary of DocMorris AG (“Doc Morris”), as it launched an approximately CHF 45 million senior unsecured convertible bond placement. Guaranteed by DocMorris, these bonds due 2028 are convertible into DocMorris shares and were issued to fund the early buyback of the outstanding CHF 87.6 million convertible bonds due in September 2026. The initiative was intended to strengthen DocMorris’ balance sheet and to reduce funding costs to support continued growth.

Following successful pricing and allocation of the new bonds, DocMorris Finance B.V. invited eligible holders of the 2026 bonds to participate in a tender offer with a repurchase price of CHF 1,035 per bond plus accrued interest. The number of bonds tendered amounted to 72,713, corresponding to a total nominal value of CHF 72,713,000.

Joint bookrunners BofA Securities Europe SA and UBS AG managed the offering and repurchase.

Baker McKenzie advised Doc Morris Finance B.V. on all legal and tax aspects of this transaction.

Swiss capital markets partners Matthias Courvoisier and Yves Mauchle led the Baker McKenzie team, which included Zurich-based Susanne Liebel-Kotz (partner, tax), Kiara Sharifi, Victoria Brammer (both associates, capital markets) as well as Amsterdam-based Tim Alferink (partner, capital markets) and Willem van Rees (associate, banking and finance).